Posts by Manisha Samy

Manisha’s Top Stock for March 2021

Manisha's Top Stock for March 2021 is an under-the-radar microbiome company with a revolutionary technology platform.

Mar 1, 2021 - By Manisha Samy

Biotechnology

What FinTwit Isn’t Telling You About These Biotech Stocks

When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and...

Feb 23, 2021 - By Manisha Samy

Biotechnology

Article

The Importance of Mission Statements in Healthcare

Manisha Samy explains how a company's mission statement is essentially an "elevator pitch" for the business.

Feb 22, 2021 - By Manisha Samy

Healthcare Technology

Premium Advisor Update

The Alzheimer’s Saga Continues

Feb 15, 2021 - By Manisha Samy

Biotechnology

Livestream

7investing Now #51: How to Build a Long-term Investing Mindset

We’ve heard a lot recently about how the individual investor can’t compete with the big guys and hedge funds. That’s true when it comes to being a trader -- you can’t beat the computers and the big...

Feb 15, 2021 - By Daniel Kline

Podcast

Navigating Next-Generation Cellular Therapies

Lead Advisor Manisha Samy sits down with the Senior Vice President of Corporate Strategy and Finance of Cellectis, Simon Harnest, to discuss the complexities of creating an allogeneic approach for...

Feb 3, 2021 - By Manisha Samy

Biotechnology

Premium Deep Dive

Invitae Deep Dive: February 2021

Feb 1, 2021 - By Manisha Samy

Healthcare Technology

Video

Manisha’s Top Stock for February 2021

7investing Lead Advisor Manisha Samy's Top Stock for February is a company that is completely re-defining the healthcare landscape with the democratization of genetic information.

Feb 1, 2021 - By Manisha Samy

Healthcare Technology

Premium Advisor Update

On the Future of DNA Sequencing

Jan 15, 2021 - By Manisha Samy

Biotechnology

Podcast

JPM 39th Annual Healthcare Conference: What We’re Watching

The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of...

Jan 7, 2021 - By Manisha Samy

Biotechnology

Premium Deep Dive

Intellia Deep Dive: January 2021

Jan 1, 2021 - By Manisha Samy

Biotechnology

Video

Manisha’s Top Stock for January

7investing Lead Advisor Manisha Samy’s Top Stock for January is applying breakthrough technologies towards providing one-course treatments for rare, life-threatening diseases.

Jan 1, 2021 - By Manisha Samy

Biotechnology

Article

Out with the Old and In with the New

Manisha Samy discusses the challenges of adapting valuation techniques at the pace of technology.

Dec 22, 2020 - By Manisha Samy

Biotechnology

Video

Manisha’s Top Stock for December

7investing advisor Manisha Samy's Top Stock for December is empowering the development and commercialization of novel genomic medicines.

Dec 1, 2020 - By Manisha Samy

Biotechnology

Premium Advisor Update

A Potential Best-Selling Drug Faces Roadblocks

Nov 15, 2020 - By Manisha Samy

Biotechnology

Posts by Manisha Samy

Video

Manisha’s Top Stock for March 2021

Podcast

What FinTwit Isn’t Telling You About These Biotech Stocks

Article

The Importance of Mission Statements in Healthcare

Premium Advisor Update

The Alzheimer’s Saga Continues

Livestream

7investing Now #51: How to Build a Long-term Investing Mindset

Podcast

Navigating Next-Generation Cellular Therapies

Premium Deep Dive

Invitae Deep Dive: February 2021

Video

Manisha’s Top Stock for February 2021

Premium Advisor Update

On the Future of DNA Sequencing

Podcast

JPM 39th Annual Healthcare Conference: What We’re Watching

Premium Deep Dive

Intellia Deep Dive: January 2021

Video

Manisha’s Top Stock for January

Article

Out with the Old and In with the New

Premium Advisor Update

Are We Human or Bacteria?

Podcast

ASH Conference Preview: What We’re Watching

Video

Manisha’s Top Stock for December

Premium Deep Dive

Cellectis Deep Dive: December 2020

Article

Set the Trend

Premium Advisor Update

A Potential Best-Selling Drug Faces Roadblocks